港股市场今日盘中，春立医疗（01858）股价大涨7.17%，引发市场关注。该公司近期公布的年度财报和未来发展规划成为推动股价上涨的主要因素。
春立医疗最新公布的全年财报显示，尽管受到集采影响，公司2024年营业额和纯利均有所下滑，分别为8.06亿元人民币和1.25亿元。然而，公司海外业务表现亮眼，2024年境外业务收入达3.53亿元，同比大幅增长78%，毛利率提升2.10个百分点至65.90%。这一强劲增长显示了公司在国际市场的竞争力和发展潜力。
此外，春立医疗公布了2024-2026年股东分红回报规划，明确在盈利且累计未分配利润为正的情况下，每年现金分红比例不低于可供股东分配利润的10%。这一举措有望提升投资者回报，增强市场信心。分析师普遍认为，虽然公司2024年业绩受到集采影响，但境内业务有望从2025年第二季度开始逐步复苏。这些积极因素综合作用，推动了春立医疗股价的大幅上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.